©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Figure 10 Alterations in the BCL-2/BAX/caspase-3 pathway.
A: Pathway proteins BCL2/BAX expression after overexpression plasmid transfection; B: Pathway proteins cleaved caspase 3/caspase 3 expression after overexpression plasmid transfection; C: BCL2/BAX expression after siRNA transfection; D: Cleaved caspase 3/caspase 3 expression after siRNA transfection. aP < 0.01, bP < 0.05.
- Citation: Guo W, Wang MX, Mu T, Xu K, Jiang ZD, Wan XH, Li JW, Yi YX. Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 111454
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/111454.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.111454